Narrow search
Showing 1 - 10 of 292,085
Cover Image
The impact of higher standards in patent protection for pharmaceutical industries under the TRIPS Agreement : a comparative study of China and India
Li, Xuan (contributor) - 2008
regimes. It is found that relative to India, which had implemented process patent until 2005, China with a product patent … anticompetitive effect in designing patent policies. -- product patent ; process patent ; TRIPS ; pharmaceutical industries ; China … literature). Also, China lags behind in both lower R&D investment and patents filed by Chinese nationals. Based on these findings …
Persistent link: https://www.econbiz.de/10003725601
Cover Image
The Impact of Higher Standards in Patent Protection for Pharmaceutical Industries under the TRIPS Agreement: A Comparative Study of China and India
Li, Xuan - World Institute for Development Economic Research … - 2008
regimes. It is found that relative to India, which had implemented process patent until 2005, China with a product patent … literature). Also, China lags behind in both lower R&D investment and patents filed by Chinese nationals. Based on these findings … and associated legal interpretation, we conclude that higher patent protection in China generates negative impacts on the …
Persistent link: https://www.econbiz.de/10005001271
Cover Image
Compulsory licensing : India's maiden experience
Gautam, Savita; Dasgupta, Meghna - 2013
Under the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) all parties to the agreement are … markets. India made use of this flexibility in March 2012 when it granted its first compulsory license to a domestic company … related to this case. An assessment of the compulsory licensing provisions under the TRIPS agreement and the Indian Patent Act …
Persistent link: https://www.econbiz.de/10010211996
Cover Image
First-Mover Advantages Before and After TRIPS : Evidence from the Indian Pharmaceutical Industry
Bhaskarabhatla, Ajay; Chatterjee, Chirantan - 2014
Scholars argue that the presence of persistent first-mover advantages obviates the need for relatively long-lived patents as incentives for innovations. What then is the impact of the strengthening of patent protection, particularly in developing economies, on non-patent-based first-mover...
Persistent link: https://www.econbiz.de/10014040093
Cover Image
The US Patent Holdings of Homegrown Indian Biotech and Pharma Companies
Sundaramoorthy, Sriramkumar; Yerram, Chandra Bindu; … - 2016
snapshot of the biotech industry in India today. It will serve as a baseline for the scenario in future. (Article freely …
Persistent link: https://www.econbiz.de/10014129813
Cover Image
Patent Holdings of Indian Pharmaceutical and Biotechnology Companies in International Markets of Different Sizes
Sebastian, Teena; Pattnayak, Jyothi; Soby, Sajna; … - 2016
In any assessment of the R&D capabilities of Indian companies, their patent holdings would have to be examined. Here we identify the number of patents assigned by four foreign governments to Indian pharmaceutical and biotechnological companies up to December 31, 2009. It is known that the United...
Persistent link: https://www.econbiz.de/10014130598
Cover Image
Patent Maintenance by Indian Pharma and Bio-Pharma Companies
Kumari, Sangita; Saberwal, Gayatri - 2016
Patents are important for biotechnology and pharmaceutical companies. In order to remain valid, an issued patent has to be ‘maintained’ by the payment of fees to the patent office at three well-defined times over several years. The article examines whether Indian companies in these sectors...
Persistent link: https://www.econbiz.de/10014130632
Cover Image
The Welfare Implications of Patent Protection, Pricing, and Licensing in the Indian Oral Anti-Diabetic Drug Market
Chatterjee, Chirantan - 2015
which are under patent protection in India. The Indian prices of DPP-4 inhibitors are higher than those of other drugs in … demand model to market data from IMS India. The model allows us to calculate consumer welfare, under the status quo as well …
Persistent link: https://www.econbiz.de/10013035611
Cover Image
Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment? A Cross-Country Analysis of Pharmaceutical Patent Protection, 1978-2002
Qian, Yi - 2014
This paper evaluates the effects of patent protection on pharmaceutical innovations for twenty-six countries that established pharmaceutical patent laws during 1978-2002. Controlling for country characteristics through matched sampling techniques to establish two proper comparison sets among...
Persistent link: https://www.econbiz.de/10012751759
Cover Image
Big pharma and monopoly capitalism: a long-term view
Dosi, Giovanni; Marengo, Luigi; Staccioli, Jacopo; … - 2021
Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...
Persistent link: https://www.econbiz.de/10012604733